Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study (Q33445014)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study
scientific article

    Statements

    Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit